{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:55:06Z","timestamp":1791219306064,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100031580","name":"National Vaccine Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031580","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["FF67"],"award-info":[{"award-number":["FF67"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009101","name":"Shanghai Academy of Spaceflight Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000858","name":"University of Sheffield","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbrc.2025.152408","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T22:58:55Z","timestamp":1753484335000},"page":"152408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A heterologous prime-boost regimen using BCG and an mRNA encoding Ag85B heightens immune response in mice"],"prefix":"10.1016","volume":"778","author":[{"given":"Chitsuda","family":"Pongma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pornlapat","family":"Keawvilai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thitiporn","family":"Pattarakankul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4578-1560","authenticated-orcid":false,"given":"Suwatchareeporn","family":"Rotcheewaphan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad-Gabriel","family":"Alameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eakachai","family":"Prompetchara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pornpimol","family":"Premchaiporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Promchat","family":"Chareanpat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wandee","family":"Yindeeyoungyeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9499-2028","authenticated-orcid":false,"given":"James","family":"Heyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1965-5491","authenticated-orcid":false,"given":"Kieu","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiat","family":"Ruxrungtham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8734-6626","authenticated-orcid":false,"given":"Tanapat","family":"Palaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152408_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00100-19","article-title":"Tuberculosis vaccine development: progress in clinical evaluation","volume":"33","author":"Sable","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bbrc.2025.152408_bib2","series-title":"Global Tuberculosis Report","year":"2023"},{"key":"10.1016\/j.bbrc.2025.152408_bib3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2025.152408_bib4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbrc.2025.152408_bib5","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1016\/j.vaccine.2011.07.109","article-title":"Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis","volume":"29","author":"West","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.152408_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.152408_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1472-6750-10-77","article-title":"Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis","volume":"10","author":"Lorenzi","year":"2010","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.bbrc.2025.152408_bib8","article-title":"An LNP-mRNA vaccine provides potent immunogenicity and protection against Mycobacterium tuberculosis","author":"Lukeman","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbrc.2025.152408_bib9","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.micinf.2005.03.009","article-title":"Prime-boost immunisation strategies for tuberculosis","volume":"7","author":"McShane","year":"2005","journal-title":"Microb. Infect."},{"key":"10.1016\/j.bbrc.2025.152408_bib10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.vaccine.2013.11.045","article-title":"Comparison of the immunogenicity and protection against Bovine tuberculosis following immunization by BCG-Priming and boosting with adenovirus or protein based vaccines","volume":"32","author":"Dean","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.152408_bib11","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.vaccine.2012.01.048","article-title":"A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-Induced human immunity","volume":"30","author":"Hoft","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.152408_bib12","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1128\/CVI.00275-12","article-title":"Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis","volume":"19","author":"Perez de Val","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.bbrc.2025.152408_bib13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.vaccine.2012.11.042","article-title":"Prime-boost BCG vaccination with DNA vaccines based in beta-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model","volume":"31","author":"Cervantes-Villagrana","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.152408_bib14","article-title":"Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against Mycobacterium tuberculosis in mice","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2025.152408_bib15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/mr.56.4.648-661.1992","article-title":"The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis","volume":"56","author":"Wiker","year":"1992","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.bbrc.2025.152408_bib16","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/iai.62.6.2536-2544.1994","article-title":"Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins","volume":"62","author":"Andersen","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2025.152408_bib17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/IAI.71.1.483-493.2003","article-title":"Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis","volume":"71","author":"D'Souza","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2025.152408_bib18","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.3892\/mmr.2015.3770","article-title":"Prime-boost vaccination with bacillus calmette guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice","volume":"12","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2025.152408_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/dna.2007.0648","article-title":"Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis","volume":"27","author":"Chang-hong","year":"2008","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bbrc.2025.152408_bib20","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.ymthe.2020.04.018","article-title":"A multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice","volume":"28","author":"Freyn","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2025.152408_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA","volume":"15","author":"Baiersdorfer","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbrc.2025.152408_bib22","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1038\/s41598-020-60223-y","article-title":"Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells","volume":"10","author":"Painter","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.152408_bib23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.12688\/f1000research.51640.1","article-title":"The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells","volume":"10","author":"Tanner","year":"2021","journal-title":"F1000Res"},{"key":"10.1016\/j.bbrc.2025.152408_bib24","series-title":"Ex Vivo Mycobacterial Growth Inhibition Assay (MGIA) for Tuberculosis Vaccine testing-a Protocol for Mouse Splenocytes","author":"Zelmer","year":"2015"},{"key":"10.1016\/j.bbrc.2025.152408_bib25","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1038\/s41598-017-02116-1","article-title":"Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis","volume":"7","author":"Jensen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.152408_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1473-3099(07)70108-1","article-title":"Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development","volume":"7","author":"Gagneux","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbrc.2025.152408_bib27","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases - advances, challenges and opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.152408_bib28","article-title":"An overview of the development of new vaccines for tuberculosis","volume":"8","author":"Whitlow","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2025.152408_bib29","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.ijid.2023.03.035","article-title":"Tuberculosis vaccines update: is an RNA-Based vaccine feasible for tuberculosis?","volume":"130","author":"Larsen","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bbrc.2025.152408_bib30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1099\/jmm.0.004267-0","article-title":"Enhanced immune response and protection efficacy of a DNA vaccine constructed by linkage of the Mycobacterium tuberculosis Ag85B-encoding gene with the BVP22-encoding gene","volume":"58","author":"Yao","year":"2009","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.bbrc.2025.152408_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nm.1928","article-title":"Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells","volume":"15","author":"Jagannath","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.bbrc.2025.152408_bib32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0264-410X(96)00274-5","article-title":"Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex","volume":"15","author":"Lozes","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.152408_bib33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.vaccine.2012.11.075","article-title":"Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system","volume":"31","author":"Meerak","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.152408_bib34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4014\/jmb.1809.09049","article-title":"Oxidized carbon nanosphere-based subunit vaccine delivery system elicited robust Th1 and cytotoxic T cell responses","volume":"29","author":"Sawutdeechaikul","year":"2019","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbrc.2025.152408_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.bbrc.2025.152408_bib36","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3892\/mmr.2016.5364","article-title":"Ag85A\/ESAT-6 chimeric DNA vaccine induces an adverse response in tuberculosis-infected mice","volume":"14","author":"Liang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2025.152408_bib37","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1586\/erv.11.144","article-title":"Do new TB vaccines have a place in the expanded program on immunization?","volume":"10","author":"McMurray","year":"2011","journal-title":"Expet Rev. Vaccine"},{"key":"10.1016\/j.bbrc.2025.152408_bib38","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/IAI.00685-08","article-title":"Immunogenicity and protective efficacy of prime-boost regimens with recombinant \u0394 ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus Ankara expressing M. tuberculosis antigen 85A against Murine tuberculosis","volume":"77","author":"Tchilian","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2025.152408_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-3083.2011.02629.x","article-title":"Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B\u2010ESAT6 fusion protein, but not an adenovirus\u2010based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis","volume":"75","author":"You","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bbrc.2025.152408_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143552","article-title":"A novel MVA-Based multiphasic vaccine for prevention or treatment of tuberculosis induces broad and multifunctional cell-mediated immunity in mice and Primates","volume":"10","author":"Leung-Theung-Long","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.152408_bib41","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.vaccine.2021.01.071","article-title":"Intranasal boosting with MVA encoding secreted mycobacterial proteins Ag85A and ESAT-6 generates strong pulmonary immune responses and protection against M. tuberculosis in mice given BCG as neonates","volume":"39","author":"Khanna","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.152408_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051396","article-title":"Vaccination with a BCG strain overexpressing Ag85B protects cattle against Mycobacterium bovis challenge","volume":"7","author":"Rizzi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.152408_bib43","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41565-023-01404-4","article-title":"Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines","volume":"18","author":"Han","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bbrc.2025.152408_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41541-024-00901-4","article-title":"Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model","volume":"9","author":"England","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.bbrc.2025.152408_bib45","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/s41467-023-37795-0","article-title":"Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice","volume":"14","author":"Prompetchara","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.152408_bib46","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.virs.2022.07.003","article-title":"A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice","volume":"37","author":"He","year":"2022","journal-title":"Virol. Sin."},{"key":"10.1016\/j.bbrc.2025.152408_bib47","first-page":"724","article-title":"The chemical composition of the active principle of tuberculin: XV. Precipitated purified tuberculin protein suitable for the preparation of a standard tuberculin","volume":"25","author":"Seibert","year":"1932","journal-title":"Am. Rev. Tubercul."},{"key":"10.1016\/j.bbrc.2025.152408_bib48","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1080\/21645515.2021.2007711","article-title":"BCG vaccination strategies against tuberculosis: updates and perspectives","volume":"17","author":"Qu","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.bbrc.2025.152408_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.152408_bib50","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2025.152408_bib51","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1038\/s41598-020-60223-y","article-title":"Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells","volume":"10","author":"Painter","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.152408_bib52","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tube.2013.04.007","article-title":"Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. Tb)","volume":"93","author":"Marsay","year":"2013","journal-title":"Tuberculosis"},{"key":"10.1016\/j.bbrc.2025.152408_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-016-1751-4","article-title":"A new tool for tuberculosis vaccine screening: ex vivo mycobacterial growth inhibition assay indicates BCG-Mediated protection in a murine model of tuberculosis","volume":"16","author":"Zelmer","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bbrc.2025.152408_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1355983","article-title":"Development and application of the direct mycobacterial growth inhibition assay: a systematic review","volume":"15","author":"Painter","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.152408_bib55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41541-024-00906-z","article-title":"A modified mycobacterial growth inhibition assay for the functional assessment of vaccine-mediated immunity","volume":"9","author":"Vergara","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.bbrc.2025.152408_bib56","doi-asserted-by":"crossref","first-page":"e1220","DOI":"10.1016\/S2214-109X(22)00325-4","article-title":"Infant BCG vaccination is beneficial, but not sufficient","volume":"10","author":"Hatherill","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.bbrc.2025.152408_bib57","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172510","article-title":"Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine","volume":"8","author":"Kingstad-Bakke","year":"2023","journal-title":"JCI Insight"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25011234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25011234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:25:03Z","timestamp":1772771103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25011234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":57,"alternative-id":["S0006291X25011234"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152408","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A heterologous prime-boost regimen using BCG and an mRNA encoding Ag85B heightens immune response in mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152408"}}